<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-06189R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0004061</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology/Gene Expression</subject><subject>Genetics and Genomics/Gene Function</subject><subject>Cardiovascular Disorders/Vascular Biology</subject></subj-group></article-categories><title-group><article-title><italic>SDF1</italic> Gene Variation Is Associated with Circulating SDF1&#x003b1; Level and Endothelial Progenitor Cell Number&#x02013;The Bruneck Study</article-title><alt-title alt-title-type="running-head">SDF1 Gene Variation and EPC</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xiao</surname><given-names>Qingzhong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ye</surname><given-names>Shu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Oberhollenzer</surname><given-names>Friedrich</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mayr</surname><given-names>Agnes</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Jahangiri</surname><given-names>Marjan</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Willeit</surname><given-names>Johann</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kiechl</surname><given-names>Stefan</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Qingbo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Cardiovascular Division, King's College London BHF Centre, London, United Kingdom</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Internal and Laboratory Medicine, Bruneck Hospital, Bruneck, Italy</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of Cardiothoracic Surgery, St. George's Hospital, London, United Kingdom</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Reitsma</surname><given-names>Pieter H.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Leiden University Medical Center, Netherlands</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>qingbo.xu@kcl.ac.uk</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: QX MJ QX. Performed the experiments: QX SY FO AM JW SK. Analyzed the data: QX SY SK. Contributed reagents/materials/analysis tools: QX MJ QX. Wrote the paper: QX SY SK QX.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>30</day><month>12</month><year>2008</year></pub-date><volume>3</volume><issue>12</issue><elocation-id>e4061</elocation-id><history><date date-type="received"><day>2</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>1</day><month>12</month><year>2008</year></date></history><copyright-statement>Xiao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><sec><title>Background</title><p>Stromal cell-derived factor-1 (SDF1) and its receptor CXC chemokine receptor 4 (CXCR4) play a critical role in progenitor cell homing, mobilization and differentiation. It would be interesting to assess the predictive value of SDF-1alpha level for EPC number, and to ascertain whether there is a relationship between <italic>SDF1</italic> gene variation, plasma SDF-1alpha level, and the number and function of circulating EPCs. We also tested whether EPC number and function was related to CXCR4 gene variation.</p></sec><sec><title>Methodology and Principal Findings</title><p>We genotyped a cohort of individuals who participated in the Bruneck Study for single nucleotide polymorphisms (SNPs) in the <italic>SDF1</italic> and <italic>CXCR4</italic> genes, and measured blood SDF1&#x003b1; level as well as EPC number and function. SDF1&#x003b1; levels were correlated with age, gender, alcohol consumption, circulating reticulocyte numbers, and concentrations of matrix metalloproteinase-9, C-reactive protein, cystatin C, fibrinogen and homocytein. In blood samples taken in 2005, EPC number was inversely associated with SDF1&#x003b1; level (p&#x0003c;0.001). EPC number in 2005 was also inversely associated with SDF1&#x003b1; level in 2000 (p&#x0200a;&#x0003d;&#x0200a;0.009), suggesting a predictive value of plasma SDF1&#x003b1; level for EPC number. There was an association between the <italic>SDF1</italic> gene rs2297630 SNP A/A genotype, increased SDF1&#x003b1; level (p&#x0200a;&#x0003d;&#x0200a;0.002) and lower EPC number (p&#x0200a;&#x0003d;&#x0200a;0.006).</p></sec><sec><title>Conclusions</title><p>Our data indicate that a SDF1 gene variation (rs2297630) has an influence on SDF1&#x003b1; level and circulating EPC number, and that plasma SDF1&#x003b1; level is a predictor of EPC number.</p></sec></abstract><counts><page-count count="7"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Asahara and colleagues in 1997 demonstrated for the first time that purified CD34 positive haematopoietic progenitor cells from peripheral blood could differentiate, ex-vivo, into an endothelial phenotype and were named Endothelial Progenitor Cells (EPCs)<xref ref-type="bibr" rid="pone.0004061-Asahara1">&#x0005b;1&#x0005d;</xref>. Growing evidence indicates that EPCs play a major role in angiogenesis and vasculogenesis<xref ref-type="bibr" rid="pone.0004061-Kalka1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Takahashi1">&#x0005b;3&#x0005d;</xref>. Indeed, mobilized EPCs can promote new blood vessel formation in ischaemic tissues, enhancing perfusion and recovery<xref ref-type="bibr" rid="pone.0004061-Kalka1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Takahashi1">&#x0005b;3&#x0005d;</xref>. Ex vivo expanded EPCs isolated from peripheral blood can also incorporate into the site of myocardial neovascularization<xref ref-type="bibr" rid="pone.0004061-Kawamoto1">&#x0005b;4&#x0005d;</xref>, and intracoronary infusion of peripheral blood or bone marrow-derived progenitors in patients with acute myocardial infarction was shown to significantly enhance post-infarction remodelling<xref ref-type="bibr" rid="pone.0004061-Britten1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Schachinger1">&#x0005b;6&#x0005d;</xref>. Moreover, EPC numbers have a prognostic value and can be used as a predictive biomarker in the cardiovascular diseases<xref ref-type="bibr" rid="pone.0004061-Vasa1">&#x0005b;7&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004061-Hill1">&#x0005b;9&#x0005d;</xref>. Other investigators have also shown reduced EPC number in patients with risk factors for cardiovascular diseases such as diabetes<xref ref-type="bibr" rid="pone.0004061-Fadini1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Tepper1">&#x0005b;11&#x0005d;</xref> and smoking<xref ref-type="bibr" rid="pone.0004061-Kondo1">&#x0005b;12&#x0005d;</xref>, with cessation of smoking resulting in a return of EPC numbers to normal. EPC number is also reduced in groups of patients known to be at higher risk of cardiovascular disease such as those with rheumatoid arthritis<xref ref-type="bibr" rid="pone.0004061-Grisar1">&#x0005b;13&#x0005d;</xref> or chronic renal failure<xref ref-type="bibr" rid="pone.0004061-Choi1">&#x0005b;14&#x0005d;</xref>. EPC number is also known to be reduced in established non-coronary cardiovascular disorders such as in patients with strokes<xref ref-type="bibr" rid="pone.0004061-Ghani1">&#x0005b;15&#x0005d;</xref>, peripheral vascular disease<xref ref-type="bibr" rid="pone.0004061-Fadini1">&#x0005b;10&#x0005d;</xref> and patients with erectile dysfunction<xref ref-type="bibr" rid="pone.0004061-Foresta1">&#x0005b;16&#x0005d;</xref>. However, our recent data from a population-based, longitudinal study refuted the traditional view that the EPC number is negatively related to cardiovascular risk factors. We showed that changes of EPC numbers are loosely associated with certain risk factors for the cardiovascular disease and not directly associate with the disease development<xref ref-type="bibr" rid="pone.0004061-Xiao1">&#x0005b;17&#x0005d;</xref>.</p><p>Animal studies have indicated that SDF1 (also known as CXC chemokine ligans 12) and its receptor CXC chemokine receptor 4 (CXCR4) plays a critical role in progenitor cell homing, mobilization and differentiation. Inactivation of the <italic>SDF1</italic> or <italic>CXCR4</italic> gene in mice led to early embryonic lethality due to abnormality in the cerebellar and gastrointestinal vasculature and in hematopoiesis development<xref ref-type="bibr" rid="pone.0004061-Nagasawa1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004061-Zou1">&#x0005b;20&#x0005d;</xref>. The number of circulating hematopoietic stem cells (HSCs) or EPCs were increased by <italic>SDF1</italic> gene transfer using the adenovirus infection technique<xref ref-type="bibr" rid="pone.0004061-Heissig1">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004061-Moore1">&#x0005b;23&#x0005d;</xref>. Overexpression of SDF1 in ischemic tissues has been found to enhance EPC recruitment from peripheral blood and to induce neoangiogenesis in ischemic tissues<xref ref-type="bibr" rid="pone.0004061-Yamaguchi1">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Hiasa1">&#x0005b;25&#x0005d;</xref>. Recent evidence also suggests that SDF1&#x003b1; is a driving force for EPC differentiation<xref ref-type="bibr" rid="pone.0004061-DeFalco1">&#x0005b;26&#x0005d;</xref>. All these findings from animal studies strongly suggest that SDF1&#x003b1; has a crucial role in stem/progenitor cell mobilization, differentiation, and injured tissues-specific homing. However, it remained unknown whether SDF1&#x003b1; played such a role in humans. Therefore, we recently examined the levels of SDF1&#x003b1; and several angiogenic cytokines in relation to circulating EPC numbers in a population-based study. We found that plasma levels of SDF1&#x003b1;, but not VEGF or G-CSF, were strongly associated with EPC number and function, suggesting a role of SDF1&#x003b1; in EPC mobilization and differentiation in humans<xref ref-type="bibr" rid="pone.0004061-Xiao1">&#x0005b;17&#x0005d;</xref>. In that study, the association of SDF1&#x003b1; levels with EPC numbers was detected using blood samples taken at the same time point. In the present study, we investigated whether SDF1&#x003b1; levels had a long-term predictive value for EPC numbers.</p><p>There is emerging evidence indicating that variation in the human <italic>SDF1</italic> gene can have an influence on SDF1&#x003b1; levels<xref ref-type="bibr" rid="pone.0004061-Kimura1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Soriano1">&#x0005b;28&#x0005d;</xref>, which was demonstrated clearly to be involved in progenitor cell mobilization and differentiation in human and animal studies. Moreover, previous study showed that EPC number is, at least in part, genetically regulated<xref ref-type="bibr" rid="pone.0004061-Whittaker1">&#x0005b;29&#x0005d;</xref>, and the presence of SDF1-3'A allele was a predictive factor of CD34<sup>&#x0002b;</sup> cell mobilization<xref ref-type="bibr" rid="pone.0004061-Benboubker1">&#x0005b;30&#x0005d;</xref>, which prompt us to hypothesize that the SDF-1 gene single-nucleotide polymorphism (SNP) might involve in their gene transcription and progenitor cell mobilization, differentiation and homing. In the present study, we examined whether there was a relationship between <italic>SDF1</italic> gene variation, SDF1&#x003b1; level and circulating EPC number. In addition, we tested whether there was also a relationship between variation in the gene encoding the SDF1&#x003b1; receptor CXCR4 and EPC number.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Study Population and clinical variables</title><p>The subjects of this study were residents of the Bruneck area in the Bolzano Province of Italy, who participated in the Bruneck Study<xref ref-type="bibr" rid="pone.0004061-Xu1">&#x0005b;31&#x0005d;</xref>. Details of the Bruneck study have been described previously<xref ref-type="bibr" rid="pone.0004061-Xu1">&#x0005b;31&#x0005d;</xref>. DNA samples were available for 826 subjects, and these were genotyped single nucleotide polymorphisms (SNPs) in the <italic>SDF1</italic> and <italic>CXCR4</italic> genes. Blood samples taken in 2000 (n&#x0200a;&#x0003d;&#x0200a;684) and 2005 (n&#x0200a;&#x0003d;&#x0200a;574) respectively were used for measurements of SDF1&#x003b1; levels. EPC number and function were assessed in blood samples collected in 2005 (n&#x0200a;&#x0003d;&#x0200a;571 for EPC number and n&#x0200a;&#x0003d;&#x0200a;542 for EPC colonies number respectively). Subjects with and those without EPC number and EPC function assessments did not differ in age, sex and cardiovascular risk factors. The appropriate ethics committees (Autonome Provinz Bozen-Sanitatsbetrieb Bozen Ethikkomittee) approved the study protocol and all study subjects gave their written informed consent before entering the study.</p><p>Systolic and diastolic blood pressure was taken with a standard mercury sphygmomanometer after at least 10 min of rest (mean of three independent measurements). Hypertension was defined as blood pressure &#x02265;140/90 mm Hg or the use of anti-hypertensive drugs. The average number of cigarettes smoked per day was noted for each smoker and ex-smoker. Diabetes was diagnosed according to ADA criteria. Assessment of regular alcohol consumption was performed with a standardized questionnaireand quantified in terms of grams per day (g/day).</p></sec><sec id="s2b"><title>EPC culture assay</title><p>EPC numbers in the blood samples were determined as described previously<xref ref-type="bibr" rid="pone.0004061-Xiao1">&#x0005b;17&#x0005d;</xref>. Briefly, positive stained cells for DiI-Ac-LDL and Lectin were considered to be EPCs on day 5 of culture. The total numbers of EPC per well were counted by two trained independent senior investigators blinded to the clinical details of the subjects. The EPC in a minimum of two wells were counted and the average was then recorded.</p></sec><sec id="s2c"><title>EPC-colony formation unit (CFU) assay</title><p>The EPC-CFU assay performed as described previously<xref ref-type="bibr" rid="pone.0004061-Xiao1">&#x0005b;17&#x0005d;</xref>. Briefly, PBMNC were resuspended in EPC culture medium (M199 with 20&#x00025;FCS and antibiotics) and then plated on fibronectin coated 6 well plates at a concentration of 5 million cells per well. The endothelial colonies were counted manually on day 7. Strict guidelines were followed to ensure consistent counting of EPC colonies. Two senior investigators who were blinded to the subjects' clinical status counted the colonies.</p></sec><sec id="s2d"><title>Enzyme-linked immunosorbent assay (ELISA)</title><p>Commercially available SDF1&#x003b1; and matrix metalloproteinase-9 (MMP9) ELISA kits (Quantikine, R&#x00026;D Systems, UK) were used to determine plasma SDF1&#x003b1; and MMP9 levels. All ELISA tests were carried out at room temperature on freshly thawed plasma samples. The concentration was determined by comparison with a standard curve, following manufacturer's instruction. Other laboratory parameters and vascular risk factors were all examined by standard methods<xref ref-type="bibr" rid="pone.0004061-Xu2">&#x0005b;32&#x0005d;</xref>.</p></sec><sec id="s2e"><title>Genotype analyses</title><p>We selected tagging SNPs in the <italic>SDF1</italic> and <italic>CXCR4</italic> genes from the HapMap database (data release in June 2005). Three SNPs in <italic>SDF1</italic> (rs2297630, rs266087 and rs1413519) and two in <italic>CXCR4</italic> (rs16832740 and rs12691874) to capture SNPs with a minor allele frequency &#x0003e;0.2 at these loci and R<sup>2</sup>&#x0003e;0.8 were typed in this study. In addition, we studied the rs266085 SNP which had been reported to influence SDF1 expression<xref ref-type="bibr" rid="pone.0004061-Kimura1">&#x0005b;27&#x0005d;</xref> and the rs1801157 SNP which had suggested to be associated with plasma SDF1 level<xref ref-type="bibr" rid="pone.0004061-Soriano1">&#x0005b;28&#x0005d;</xref>. Genomic DNA was extracted from blood samples of the Bruneck study subjects, and genotypes were determined using the TaqMan genotyping method.</p></sec><sec id="s2f"><title>Statistical Analysis</title><p>The data were analyzed using the SPSS 15.0 and BMDP software packages. Continuous variables were presented as means&#x000b1;SD or medians (interquartile range), and dichotomous variables as percentages. Correlations between EPC number and EPC-CFU, SDF1&#x003b1; level and other parameters were estimated by calculation of crude and partial (age/sex-corrected) Pearson correlation coefficients. Variables with a skewed distribution were logB<sub>eB</sub>-transformed. Non-parametric tests yielded very similar findings (data not presented). Associations of EPC number, EPC-CFU and SDF1&#x003b1; level with SDF1 and CXCR4 genotypes were assessed using generalized linear models adjusted for age and sex. Multivariate models additionally included standard cardiovascular risk factors and the factors associated with SDF1&#x003b1; levels (LDL and HDL cholesterol concentrations, smoking, hypertension, diabetes, alcohol consumption, and levels of CRP, MMP9, cystatin C, fibrinogen and homocystein). A Bonferroni correction was performed to account for the multiple comparisons (5 SNPs in SDF1 and 2 in CXCR4) performed.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Relationship of plasma SDF1&#x003b1; level with inflammatory markers and other variables</title><p>Near normal distribution of SDF1&#x003b1; was observed in our study (<xref ref-type="fig" rid="pone-0004061-g001"><bold>Figure 1A</bold></xref><bold>.</bold> Kolmogorov-Smirnov p&#x0003e;0.05<bold>)</bold>. Mean SDF1&#x003b1; levels in 2000 and 2005 were 2652 pg/ml and 2565 pg/ml, with a range of 880 pg/ml to 5595 pg/ml and 1322 pg/ml to 4174 pg/ml, respectively. SDF1&#x003b1; levels in 2000 and 2005 were highly correlated (intraclass correlation<italic>&#x0200a;&#x0003d;&#x0200a;</italic>0.495; <italic>P</italic>&#x0003c;0.001), indicating that the SDF1&#x003b1; level is relatively consistent over time. As expected, both plasma SDF1&#x003b1; level measured in 2000 (r&#x0200a;&#x0003d;&#x0200a;0.207, p&#x0003c;0.001) and 2005 (r&#x0200a;&#x0003d;&#x0200a;0.270, p&#x0003c;0.001) increased with age (<xref ref-type="fig" rid="pone-0004061-g001"><bold>Figure 1B</bold></xref>) and was higher in women (2619 in women vs. 2497 in men, p&#x0200a;&#x0003d;&#x0200a;0.002). Moreover, plasma SDF1&#x003b1; level was correlated with alcohol consumption (age/sex-adjusted correlation coefficient r&#x0200a;&#x0003d;&#x0200a;&#x02212;0.087, p&#x0200a;&#x0003d;&#x0200a;0.042), reticulocyte numbers (r&#x0200a;&#x0003d;&#x0200a;&#x02212;0.132, p&#x0200a;&#x0003d;&#x0200a;0.002), plasma levels of matrix metalloproteinase-9 (MMP9) (r&#x0200a;&#x0003d;&#x0200a;0.146, p&#x0200a;&#x0003d;&#x0200a;0.001), C-reactive protein (hsCRP) (r&#x0200a;&#x0003d;&#x0200a;0.090, p&#x0200a;&#x0003d;&#x0200a;0.037), cystatin C (r&#x0200a;&#x0003d;&#x0200a;0.277, p&#x0003c;0.001), fibrinogen (r&#x0200a;&#x0003d;&#x0200a;0.159, p&#x0003c;0.001), and homocytein (r&#x0200a;&#x0003d;&#x0200a;0.174, p&#x0200a;&#x0003d;&#x0200a;0.001). (<xref ref-type="table" rid="pone-0004061-t001"><bold>Table 1</bold></xref>)</p><fig id="pone-0004061-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004061.g001</object-id><label>Figure 1</label><caption><p>Panel A shows near normal distribution of SDF1&#x003b1; in the Bruncek study population. Panel B displays the association between SDF-1&#x003b1; measured in 2000 and in 2005 and age (r&#x0200a;&#x0003d;&#x0200a;0.270, p&#x0003c;0.001). Panel C illustrates the correlation between SDF1&#x003b1; levels and EPC number in 2005. The regression line demonstrates clearly that SDF1&#x003b1; levels are inverse association with EPC number. Panel D illustrates the association between EPC numbers in 2005 and SDF1&#x003b1; level in 2000 (tertile groups). SDF-1 tertile groups are defined as follows: T1&#x0003c;2409, T2 2409&#x02013;2753 and T3&#x0003e;2753. The box plots indicating EPC number median and IQRs. Notably, EPC numbers are significant associated inversely with SDF-1&#x003b1; levels, especially much low EPC number were likely observed in the top tertile group of SDF-1 levels.</p></caption><graphic xlink:href="pone.0004061.g001"/></fig><table-wrap id="pone-0004061-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004061.t001</object-id><label>Table 1</label><caption><title>Association between SDF-1&#x003b1; level and selected vascular risk factors and laboratory parameters (2005).</title></caption><graphic id="pone-0004061-t001-1" xlink:href="pone.0004061.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004061-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Variable</td><td colspan="3" align="left" rowspan="1">SDF-1&#x003b1; tertile group (pg/ml)</td><td align="left" rowspan="1" colspan="1">P value for trend</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Low Tertile (lower than 2350)</td><td align="left" rowspan="1" colspan="1">Medium Tertile (2350&#x02013;2743)</td><td align="left" rowspan="1" colspan="1">High Tertile (higher than 2743)</td><td align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Alcohol consumption (g/day)</td><td align="left" rowspan="1" colspan="1">21.9&#x000b1;27.4</td><td align="left" rowspan="1" colspan="1">17.9&#x000b1;23.9</td><td align="left" rowspan="1" colspan="1">15.1&#x000b1;24.5</td><td align="left" rowspan="1" colspan="1">0.042</td></tr><tr><td align="left" rowspan="1" colspan="1">Reticulocytes (&#x02030;)</td><td align="left" rowspan="1" colspan="1">12.7&#x000b1;3.42</td><td align="left" rowspan="1" colspan="1">12.2&#x000b1;3.30</td><td align="left" rowspan="1" colspan="1">11.7&#x000b1;3.15</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">MMP9 (ng/mL)</td><td align="left" rowspan="1" colspan="1">69.2&#x000b1;60.6</td><td align="left" rowspan="1" colspan="1">80.5&#x000b1;59.0</td><td align="left" rowspan="1" colspan="1">87.3&#x000b1;60.2</td><td align="left" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">High-sensitivity CRP (mg/L)</td><td align="left" rowspan="1" colspan="1">3.5&#x000b1;4.7</td><td align="left" rowspan="1" colspan="1">3.1&#x000b1;3.6</td><td align="left" rowspan="1" colspan="1">5.1&#x000b1;9.9</td><td align="left" rowspan="1" colspan="1">0.037</td></tr><tr><td align="left" rowspan="1" colspan="1">Fibrinogen (mg/dL)</td><td align="left" rowspan="1" colspan="1">285.4&#x000b1;53.8</td><td align="left" rowspan="1" colspan="1">296.4&#x000b1;54.2</td><td align="left" rowspan="1" colspan="1">311.4&#x000b1;64.2</td><td align="left" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">H<sc>omocystein</sc> (<sc>&#x000b5;mol</sc>/L)</td><td align="left" rowspan="1" colspan="1">11.6&#x000b1;5.9</td><td align="left" rowspan="1" colspan="1">11.4&#x000b1;5.0</td><td align="left" rowspan="1" colspan="1">13.7&#x000b1;7.4</td><td align="left" rowspan="1" colspan="1">0.017</td></tr><tr><td align="left" rowspan="1" colspan="1">Cystatin C (mg/L)</td><td align="left" rowspan="1" colspan="1">0.92&#x000b1;0.16</td><td align="left" rowspan="1" colspan="1">0.98&#x000b1;0.23</td><td align="left" rowspan="1" colspan="1">1.12&#x000b1;0.31</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><p>Values are means &#x000b1;SD. P values for trend are from age- and sex-adjusted analyses.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Plasma SDF1&#x003b1; level predicts EPC number</title><p>EPC number and EPC-CFU number (per 1 ml blood) displayed a non-normal distribution, with the majority of subjects (more than 75&#x00025;) having 0 to 1000 EPC and 0 to 340 EPC-CFU, respectively. SDF1&#x003b1; levels were significantly and inversely associated with EPC number (p&#x0003c;0.001) in samples collected in 2005 (<xref ref-type="fig" rid="pone-0004061-g001">Figure <bold>1C</bold></xref><bold>)</bold>, indicating that SDF1&#x003b1; has an influence on EPC number in the general population. Importantly, EPC number in 2005 was also associated with SDF1&#x003b1; level in 2000 (p&#x0200a;&#x0003d;&#x0200a;0.009), indicating a long-term predictive value of SDF1&#x003b1; level for circulating EPC number (<xref ref-type="fig" rid="pone-0004061-g001"><bold>Figure 1D</bold></xref>). No association between SDF1&#x003b1; level and EPC function measured by EPC-CFU was detected in this study.</p></sec><sec id="s3c"><title>Association of <italic>SDF1</italic> genotyping, plasma SDF1&#x003b1; level and circulating EPC number</title><p>Allele and genotype frequencies of the <italic>SDF1</italic> and <italic>CXCR4</italic> SNPs examined in this study are shown in <xref ref-type="table" rid="pone-0004061-t002"><bold>Table 2</bold></xref><bold>.</bold> The genotype distributions were consistent with Hardy-Weinberg equilibrium.</p><table-wrap id="pone-0004061-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004061.t002</object-id><label>Table 2</label><caption><title>Genotype and allele frequencies of <italic>SDF1</italic> and <italic>CXCR4</italic> SNPs studied</title></caption><graphic id="pone-0004061-t002-2" xlink:href="pone.0004061.t002"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004061-t002-2"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Gene</td><td align="left" rowspan="1" colspan="1">SNP</td><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">N (&#x00025;)</td><td align="left" rowspan="1" colspan="1">Allele</td><td align="left" rowspan="1" colspan="1">Frequency</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><italic>SDF1</italic></td><td align="left" rowspan="1" colspan="1">rs2297630</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">463 (60.05)</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.78</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">271 (35.15)</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">37 (4.80)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs266085</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">307 (42.05)</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.63</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">311 (42.60)</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.37</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">112 (15.34)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">351 (46.61)</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.37</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">104 (13.81)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs1801157</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">445 (62.94)</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.79</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">231 (32.67)</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">31 (4.38)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs1413519</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">462 (63.20)</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.79</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CG</td><td align="left" rowspan="1" colspan="1">238 (32.56)</td><td align="left" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1">31 (4.24)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><italic>CXCR4</italic></td><td align="left" rowspan="1" colspan="1">rs16832740</td><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">447 (62.34)</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.79</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">237 (33.05)</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">33 (4.60)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">rs12691874</td><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">189 (26.21)</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">0.52</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">371 (51.46)</td><td align="left" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">0.48</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">161 (22.33)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>The <italic>SDF1</italic> rs2297630 SNP was associated with plasma SDF1&#x003b1; level (p&#x0200a;&#x0003d;&#x0200a;0.002) and circulating EPC number (p&#x0200a;&#x0003d;&#x0200a;0.006), with the A/A genotype associating with higher SDF1&#x003b1; level and lower EPC number (<xref ref-type="fig" rid="pone-0004061-g002"><bold>Figure 2</bold></xref><bold> &#x00026; </bold><xref ref-type="table" rid="pone-0004061-t003"><bold>Table 3</bold></xref>). These associations remained significant after Bonferroni correction for the number of SNPs tested (Bonferroni corrected p&#x0200a;&#x0003d;&#x0200a;0.014 and p&#x0200a;&#x0003d;&#x0200a;0.042, respectively). The associations also remained significant after adjusting for cardiovascular risk factors and the factors that were associated with SDF1&#x003b1; levels, including LDL and HDL cholesterol concentrations, smoking, hypertension, diabetes, alcohol consumption, and levels of hsCRP, MMP9, cystatin C, fibrinogen and homocystein (<xref ref-type="table" rid="pone-0004061-t003"><bold>Table 3</bold></xref>).</p><fig id="pone-0004061-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004061.g002</object-id><label>Figure 2</label><caption><title>Associations of the SDF1 rs2297630 SNP (2000) with EPC number (median and IQR, A) and blood SDF1&#x003b1; level (arithmetic means and SD, B) assessed in the 2005 evaluation of the Bruneck Study.</title></caption><graphic xlink:href="pone.0004061.g002"/></fig><table-wrap id="pone-0004061-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004061.t003</object-id><label>Table 3</label><caption><title>Plasma SDF1&#x003b1; levels and circulating EPC numbers according to <italic>SDF1</italic> and <italic>CXCR4</italic> SNP genotypes.</title></caption><graphic id="pone-0004061-t003-3" xlink:href="pone.0004061.t003"/><table frame="hsides" rules="groups" alternate-form-of="pone-0004061-t003-3"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">SNP</td><td align="left" rowspan="1" colspan="1">Genotype</td><td align="left" rowspan="1" colspan="1">SDF1&#x003b1; level</td><td align="left" rowspan="1" colspan="1">P value</td><td align="left" rowspan="1" colspan="1">EPC number</td><td align="left" rowspan="1" colspan="1">P value</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SDF1 rs2297630</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">2562 (2515&#x02013;2609)</td><td align="left" rowspan="1" colspan="1">0.002</td><td align="left" rowspan="1" colspan="1">382 (336&#x02013;434)</td><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">2524 (2461&#x02013;2586)</td><td align="left" rowspan="1" colspan="1">(0.002)</td><td align="left" rowspan="1" colspan="1">409 (344&#x02013;486)</td><td align="left" rowspan="1" colspan="1">(0.015)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2863 (2684&#x02013;3043)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">175 (107&#x02013;286)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SDF1 rs266085</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">2572 (2512&#x02013;2631)</td><td align="left" rowspan="1" colspan="1">0.661</td><td align="left" rowspan="1" colspan="1">354 (300&#x02013;417)</td><td align="left" rowspan="1" colspan="1">0.793</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">2539 (2480&#x02013;2597)</td><td align="left" rowspan="1" colspan="1">(0.328)</td><td align="left" rowspan="1" colspan="1">383 (326&#x02013;449)</td><td align="left" rowspan="1" colspan="1">(0.866)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2529 (2431&#x02013;2626)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">362 (277&#x02013;473)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SDF1 rs266087</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">2570 (2510&#x02013;2630)</td><td align="left" rowspan="1" colspan="1">0.931</td><td align="left" rowspan="1" colspan="1">355 (302&#x02013;418)</td><td align="left" rowspan="1" colspan="1">0.702</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">2574 (2519&#x02013;2630)</td><td align="left" rowspan="1" colspan="1">(0.742)</td><td align="left" rowspan="1" colspan="1">391 (336&#x02013;455)</td><td align="left" rowspan="1" colspan="1">(0.803)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2552 (2450&#x02013;2654)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">378 (286&#x02013;499)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SDF1 rs1801157</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">2592 (2544&#x02013;2641)</td><td align="left" rowspan="1" colspan="1">0.260</td><td align="left" rowspan="1" colspan="1">370 (323&#x02013;425)</td><td align="left" rowspan="1" colspan="1">0.998</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">2547 (2483&#x02013;2612)</td><td align="left" rowspan="1" colspan="1">(0.208)</td><td align="left" rowspan="1" colspan="1">368 (307&#x02013;441)</td><td align="left" rowspan="1" colspan="1">(0.931)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2467 (2295&#x02013;2638)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">369 (227&#x02013;598)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">SDF1 rs1413519</td><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">2562 (2513&#x02013;2611)</td><td align="left" rowspan="1" colspan="1">0.225</td><td align="left" rowspan="1" colspan="1">338 (295&#x02013;386)</td><td align="left" rowspan="1" colspan="1">0.300</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CG</td><td align="left" rowspan="1" colspan="1">2588 (2522&#x02013;2655)</td><td align="left" rowspan="1" colspan="1">(0.222)</td><td align="left" rowspan="1" colspan="1">401 (335&#x02013;482)</td><td align="left" rowspan="1" colspan="1">(0.229)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">CC</td><td align="left" rowspan="1" colspan="1">2725 (2541&#x02013;2909)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">397 (240&#x02013;658)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CXCR4 rs16832740</td><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2557 (2509&#x02013;2606)</td><td align="left" rowspan="1" colspan="1">0.424</td><td align="left" rowspan="1" colspan="1">374 (328&#x02013;426)</td><td align="left" rowspan="1" colspan="1">0.878</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">2556 (2487&#x02013;2624)</td><td align="left" rowspan="1" colspan="1">(0.747)</td><td align="left" rowspan="1" colspan="1">395 (329&#x02013;475)</td><td align="left" rowspan="1" colspan="1">(0.783)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">2863 (2501&#x02013;2854)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">370 (230&#x02013;595)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CXCR4 rs12691874</td><td align="left" rowspan="1" colspan="1">AA</td><td align="left" rowspan="1" colspan="1">2514 (2437&#x02013;2591)</td><td align="left" rowspan="1" colspan="1">0.306</td><td align="left" rowspan="1" colspan="1">414 (336&#x02013;512)</td><td align="left" rowspan="1" colspan="1">0.272</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AG</td><td align="left" rowspan="1" colspan="1">2588 (2534&#x02013;2641)</td><td align="left" rowspan="1" colspan="1">(0.600)</td><td align="left" rowspan="1" colspan="1">362 (313&#x02013;419)</td><td align="left" rowspan="1" colspan="1">(0.169)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">GG</td><td align="left" rowspan="1" colspan="1">2571 (2488&#x02013;2654)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">322 (256&#x02013;404)</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="nt102"><p>SDF-1 levels and EPC numbers (per 1 ml blood) are age- and sex-adjusted arithmetic (95&#x00025;CI) and geometric means (95&#x00025;CI), respectively. P values are from general linear models adjusted for age and sex and in brackets from models additionally adjusted for canditate vascular risk factors and determinants of SDF-1&#x003b1; levels (LDL and HDL cholesterol &#x0005b;mg/dL&#x0005d;, smoking &#x0005b;0,1&#x0005d;, hypertension &#x0005b;0,1&#x0005d;, diabetes &#x0005b;0,1&#x0005d;, alcohol consumption &#x0005b;gram/day&#x0005d;, homocystein &#x0005b;&#x000b5;mol/L&#x0005d;, hsCRP &#x0005b;mg/L&#x0005d;, MMP9 &#x0005b;ng/mL&#x0005d;, cystatin C &#x0005b;mg/L&#x0005d;, fibrinogen &#x0005b;mg/dL&#x0005d;).</p></fn></table-wrap-foot></table-wrap><p>Plasma SDF1&#x003b1; level and circulating EPC number was not associated with the other <italic>SDF1</italic> or <italic>CXCR4</italic> SNPs tested. No association was observed between any of the SNPs tested and EPC-CFU.</p></sec></sec><sec id="s4"><title>Discussion</title><p>The population-based, longitudinal design of the Bruneck study allowed us to investigate the relationships between SDF1&#x003b1; levels at two different time points (2000 and 2005) and the relationships of the SDF1&#x003b1; levels at these different time points with circulating EPC numbers. A key finding from our study is the high degree of correlation the two SDF1&#x003b1; measurements in blood samples taken in 2000 and 2005 respectively, suggesting that although SDF1&#x003b1; levels are correlated with cardiovascular risk factors, the levels in an individual are relatively consistent over time. In addition, the study revealed an association between SDF1&#x003b1; level in 2000 and EPC number in 2005, suggesting a long-term predictive value of SDF1&#x003b1; level for EPC number. Another important, novel finding of this study is that there is an association between variation in the <italic>SDF1</italic> gene, SDF1&#x003b1; level and EPC number, indicating that the inter-individual variability in SDF1&#x003b1; level and EPC number is influenced by variation in the <italic>SDF1</italic> gene.</p><p>SDF1 is a member of the chemokine CXC subfamily originally isolated from murine bone marrow stromal cells and is expressed also by stromal cells of various tissues<xref ref-type="bibr" rid="pone.0004061-Nagasawa2">&#x0005b;33&#x0005d;</xref>. Animal studies have shown that increasing SDF expression by adenovirus gene transfer can induce EPC mobilization from bone marrow into the peripheral blood, thereby increasing circulating EPC numbers<xref ref-type="bibr" rid="pone.0004061-Heissig1">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004061-Moore1">&#x0005b;23&#x0005d;</xref>, enhancing angiogenesis and blood perfusion in ischemic tissues<xref ref-type="bibr" rid="pone.0004061-Hiasa1">&#x0005b;25&#x0005d;</xref>. These studies have led to the hypothesis that SDF1 plays an important role in EPC mobilization, differentiation and homing. However, data from our study showed that SDF-1&#x003b1; levels were inversely, rather than positively, associated with circulating EPC numbers. There are several possible explanations. Almost all of the exiting data that suggest that SDF1&#x003b1; can induce circulating EPCs are from studies in mouse, and the situations in humans may be different and more complex. Indeed, a number of studies including the present study have shown that EPC numbers in humans are related to a number of factors including age, gender, smoking, lipid levels, hypertension, diabetes, etc. Secondly, it is possible that the relationship of SDF1 with EPC mobilization, differentiation and homing in the acute phase is different from that in the normal situation. Studies of mouse ischemia models showed that the number of c-Kit<sup>&#x0002b;</sup> cells in peripheral blood was lower but the level of SDF1&#x003b1; was much higher at 14 days after ischemia, as compared with control mice<xref ref-type="bibr" rid="pone.0004061-DeFalco1">&#x0005b;26&#x0005d;</xref>, suggesting that EPCs are mobilized into peripheral blood from bone marrow after the onset of ischemia, but at a later stage, the numbers of mobilized EPC in peripheral blood decrease due to their homing to the ischemic site. Thirdly, because SDF1&#x003b1; functions as a chemoattractant for stem/progenitor cells, the SDF1&#x003b1; gradient between bone marrow, peripheral blood and injured tissue/sites is crucial for stem/progenitor cell mobilization, differentiation and homing<xref ref-type="bibr" rid="pone.0004061-DeFalco1">&#x0005b;26&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Aiuti1">&#x0005b;34&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004061-Hattori1">&#x0005b;36&#x0005d;</xref>. It has been reported that stem/progenitor cells in bone marrow and peripheral blood are mobilized and homed to the ischemic or injured tissue due to high SDF1&#x003b1; levels in the ischemic or injured tissue<xref ref-type="bibr" rid="pone.0004061-DeFalco1">&#x0005b;26&#x0005d;</xref> and lower levels of SDF-1&#x003b1; in the bone marrow<xref ref-type="bibr" rid="pone.0004061-Petit1">&#x0005b;37&#x0005d;</xref>. Measurement of plasma SDF1&#x003b1; level does not represent the gradient mention above, and therefore, the inverse relationship between plasma SDF1&#x003b1; level and circulating EPC number should not be interpreted as in conflict with the notion that SDF1 plays an important role in EPC mobilization, differentiation and homing.</p><p>A recent study showed that there is significant correlation in the number of circulating EPCs between parents and their offsprings, leading to the hypothesis that EPC number is, at least in part, genetically regulated<xref ref-type="bibr" rid="pone.0004061-Whittaker1">&#x0005b;29&#x0005d;</xref>. The results of our study support this hypothesis and indicate that such a genetic influence is likely in part due to variation in the <italic>SDF1</italic> gene. In particular, we found that SDF1&#x003b1; level and circulating EPC number are associated with the <italic>SDF1</italic> gene rs2297630 SNP in the Bruneck study cohort. A potential interpretation for this novel finding is that variation in the SDF1 gene can influence EPC number via an effect on the level of SDF1&#x003b1;. The rs2297630 SNP is located in intron 3 of the <italic>SDF1</italic> gene. It is possible that the association of this SNP with SDF1&#x003b1; level and circulating EPC number has arisen from a direct functional effect of this SNP on SDF1 expression or mRNA splicing. Alternatively, the rs2297630 SNP might be a functionally neutral marker that is in linkage disequilibrium with a functional polymorphism located elsewhere at the <italic>SDF1</italic> locus.</p><p>Two other <italic>SDF1</italic> SNPs, rs266085 and rs1801157, have been reported to be associated with SDF1 levels<xref ref-type="bibr" rid="pone.0004061-Kimura1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Soriano1">&#x0005b;28&#x0005d;</xref> and the latter SNP has also been reported to be associated with CD34<sup>&#x0002b;</sup> cell mobilization<xref ref-type="bibr" rid="pone.0004061-Benboubker1">&#x0005b;30&#x0005d;</xref>. Some, but not all, studies have suggested that the rs1801157 SNP is associated with HIV infection and AIDS<xref ref-type="bibr" rid="pone.0004061-Winkler1">&#x0005b;38&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004061-Brambilla1">&#x0005b;40&#x0005d;</xref> and there is also evidence suggesting that this SNP is associated with acute myeloid leukaemia<xref ref-type="bibr" rid="pone.0004061-Dommange1">&#x0005b;41&#x0005d;</xref>, chronic myelogenous leukaemia<xref ref-type="bibr" rid="pone.0004061-deOliveira1">&#x0005b;42&#x0005d;</xref>, colorectal cancer<xref ref-type="bibr" rid="pone.0004061-Dimberg1">&#x0005b;43&#x0005d;</xref>, sporadic breast cancer<xref ref-type="bibr" rid="pone.0004061-Zafiropoulos1">&#x0005b;44&#x0005d;</xref>, carotid artery stenosis<xref ref-type="bibr" rid="pone.0004061-Zafiropoulos1">&#x0005b;45&#x0005d;</xref>, type I diabetes<xref ref-type="bibr" rid="pone.0004061-Ghilardi1">&#x0005b;46&#x0005d;</xref> and systemic lupus erythematosus<xref ref-type="bibr" rid="pone.0004061-Ide1">&#x0005b;47&#x0005d;</xref>. However, in vitro experiments show that this SNP (rs1801157) does not have a direct functional effect on SDF1 expression<xref ref-type="bibr" rid="pone.0004061-Lima1">&#x0005b;48&#x0005d;</xref>, raising the possibility that it may be a marker for a functional SNP at the <italic>SDF1</italic> locus due to linkage disequilibrium. This possibility is consistent with the fact that the SDF1 gene is transcribed into two isoforms, SDF1&#x003b1; and SDF1&#x003b2;, and that the rs1801157 SNP is located in the 3&#x02032; untranslated region of the SDF1&#x003b2; transcript but not in the SDF1&#x003b1; transcript<xref ref-type="bibr" rid="pone.0004061-Arya1">&#x0005b;49&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Nagasawa3">&#x0005b;50&#x0005d;</xref>. In the Bruneck study cohort, we found that the rs2297630 SNP, but not the rs266085 or rs1801157 SNP, was associated with SDF1&#x003b1; level and EPC number. Taken together, the studies mentioned above and the present study suggest that variation in SDF1 gene has an influence on SDF1 levels. The populations examined in these different studies may have different genetic structure and linkage disequilibrium patterns, which may explain why different SDF1 SNPs were associated with SDF1 levels in the different studies.</p><p>Some particular attentions should be drawn regarding our findings. Firstly, the consideration of the nature of EPC is important, since there is no a unique criteria for identification of EPC, yet. Immense attention regarding the definition of EPC has recently been drawn due to the fact that the characterization and function of EPC isolated with different methodologies were quite different from each other<xref ref-type="bibr" rid="pone.0004061-Shirozu1">&#x0005b;51&#x0005d;</xref>. Myeloid PBMNC derived spindle like EPC, but not circulating CD34&#x0002b; cells was used to quantify the circulating EPC number in our study. Although a positive relationship between them was reported in the literature, the number of cultured EPC may not always reflect the number of circulating CD34&#x0002b; and/or KDR&#x0002b; EPC. Secondly, many diseases have influence on the role of EPC number, such as diabetes<xref ref-type="bibr" rid="pone.0004061-Fadini1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004061-Tepper1">&#x0005b;11&#x0005d;</xref>, smoking<xref ref-type="bibr" rid="pone.0004061-Kondo1">&#x0005b;12&#x0005d;</xref>, rheumatoid arthritis<xref ref-type="bibr" rid="pone.0004061-Grisar1">&#x0005b;13&#x0005d;</xref> or chronic renal failure<xref ref-type="bibr" rid="pone.0004061-Choi1">&#x0005b;14&#x0005d;</xref>, among them much reduced EPC number have been reported. Extensive adjustments for cardiovascular risk factors and diseases have been conducted in our study to exclude any potential influence on our findings. Finally, no relationship or association between EPC-CFU and plasma SDF-1&#x003b1; levels and SDF-1 gene SNPs were observed in our study, which indicating that neither plasma SDF-1&#x003b1; levels nor SDF-1 SNP could affect the proliferation and migration of EPC reflected by their ability to form EPC colonies in the culture.</p><p>In summary, our data indicate that although the SDF1 level and EPC number may both increase in response to acute ischaemic events, the relationship between blood SDF1 level and EPC number is complex and they are inversely correlated in the normal situation as observed in the Bruneck study cohort which was recruited from the general population. Our data also indicate that circulating EPC number is influenced by variation in the SDF1 gene likely via an effect of the genetic variation on SDF1&#x003b1; expression. These findings help understand the mechanisms underlying the inter-individual variability in EPC number which has an implication in the pathogenesis of atherosclerosis and other cardiovascular diseases.</p></sec></body><back><ref-list><title>References</title><ref id="pone.0004061-Asahara1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asahara</surname><given-names>T</given-names></name><name><surname>Murohara</surname><given-names>T</given-names></name><name><surname>Sullivan</surname><given-names>A</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><name><surname>van der Zee</surname><given-names>R</given-names></name><etal/></person-group><year>1997</year><article-title>Isolation of putative progenitor endothelial cells for angiogenesis.</article-title><source>Science</source><volume>275</volume><fpage>964</fpage><lpage>967</lpage><pub-id pub-id-type="pmid">9020076</pub-id></citation></ref><ref id="pone.0004061-Kalka1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalka</surname><given-names>C</given-names></name><name><surname>Masuda</surname><given-names>H</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Kalka-Moll</surname><given-names>WM</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.</article-title><source>Proc Natl Acad Sci U S A</source><volume>97</volume><fpage>3422</fpage><lpage>3427</lpage><pub-id pub-id-type="pmid">10725398</pub-id></citation></ref><ref id="pone.0004061-Takahashi1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Kalka</surname><given-names>C</given-names></name><name><surname>Masuda</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><etal/></person-group><year>1999</year><article-title>Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.</article-title><source>Nat Med</source><volume>5</volume><fpage>434</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">10202935</pub-id></citation></ref><ref id="pone.0004061-Kawamoto1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>A</given-names></name><name><surname>Gwon</surname><given-names>HC</given-names></name><name><surname>Iwaguro</surname><given-names>H</given-names></name><name><surname>Yamaguchi</surname><given-names>JI</given-names></name><name><surname>Uchida</surname><given-names>S</given-names></name><etal/></person-group><year>2001</year><article-title>Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia.</article-title><source>Circulation</source><volume>103</volume><fpage>634</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">11156872</pub-id></citation></ref><ref id="pone.0004061-Britten1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Britten</surname><given-names>MB</given-names></name><name><surname>Abolmaali</surname><given-names>ND</given-names></name><name><surname>Assmus</surname><given-names>B</given-names></name><name><surname>Lehmann</surname><given-names>R</given-names></name><name><surname>Honold</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.</article-title><source>Circulation</source><volume>108</volume><fpage>2212</fpage><lpage>2218</lpage><pub-id pub-id-type="pmid">14557356</pub-id></citation></ref><ref id="pone.0004061-Schachinger1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schachinger</surname><given-names>V</given-names></name><name><surname>Assmus</surname><given-names>B</given-names></name><name><surname>Britten</surname><given-names>MB</given-names></name><name><surname>Honold</surname><given-names>J</given-names></name><name><surname>Lehmann</surname><given-names>R</given-names></name><etal/></person-group><year>2004</year><article-title>Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.</article-title><source>J Am Coll Cardiol</source><volume>44</volume><fpage>1690</fpage><lpage>1699</lpage><pub-id pub-id-type="pmid">15489105</pub-id></citation></ref><ref id="pone.0004061-Vasa1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vasa</surname><given-names>M</given-names></name><name><surname>Fichtlscherer</surname><given-names>S</given-names></name><name><surname>Aicher</surname><given-names>A</given-names></name><name><surname>Adler</surname><given-names>K</given-names></name><name><surname>Urbich</surname><given-names>C</given-names></name><etal/></person-group><year>2001</year><article-title>Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.</article-title><source>Circ Res</source><volume>89</volume><fpage>E1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11440984</pub-id></citation></ref><ref id="pone.0004061-Vasa2"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vasa</surname><given-names>M</given-names></name><name><surname>Fichtlscherer</surname><given-names>S</given-names></name><name><surname>Adler</surname><given-names>K</given-names></name><name><surname>Aicher</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>H</given-names></name><etal/></person-group><year>2001</year><article-title>Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.</article-title><source>Circulation</source><volume>103</volume><fpage>2885</fpage><lpage>2890</lpage><pub-id pub-id-type="pmid">11413075</pub-id></citation></ref><ref id="pone.0004061-Hill1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>JM</given-names></name><name><surname>Zalos</surname><given-names>G</given-names></name><name><surname>Halcox</surname><given-names>JP</given-names></name><name><surname>Schenke</surname><given-names>WH</given-names></name><name><surname>Waclawiw</surname><given-names>MA</given-names></name><etal/></person-group><year>2003</year><article-title>Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.</article-title><source>N Engl J Med</source><volume>348</volume><fpage>593</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">12584367</pub-id></citation></ref><ref id="pone.0004061-Fadini1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fadini</surname><given-names>GP</given-names></name><name><surname>Miorin</surname><given-names>M</given-names></name><name><surname>Facco</surname><given-names>M</given-names></name><name><surname>Bonamico</surname><given-names>S</given-names></name><name><surname>Baesso</surname><given-names>I</given-names></name><etal/></person-group><year>2005</year><article-title>Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.</article-title><source>J Am Coll Cardiol</source><volume>45</volume><fpage>1449</fpage><lpage>1457</lpage><pub-id pub-id-type="pmid">15862417</pub-id></citation></ref><ref id="pone.0004061-Tepper1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tepper</surname><given-names>OM</given-names></name><name><surname>Galiano</surname><given-names>RD</given-names></name><name><surname>Capla</surname><given-names>JM</given-names></name><name><surname>Kalka</surname><given-names>C</given-names></name><name><surname>Gagne</surname><given-names>PJ</given-names></name><etal/></person-group><year>2002</year><article-title>Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.</article-title><source>Circulation</source><volume>106</volume><fpage>2781</fpage><lpage>2786</lpage><pub-id pub-id-type="pmid">12451003</pub-id></citation></ref><ref id="pone.0004061-Kondo1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>M</given-names></name><name><surname>Takeshita</surname><given-names>K</given-names></name><name><surname>Numaguchi</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><etal/></person-group><year>2004</year><article-title>Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>24</volume><fpage>1442</fpage><lpage>1447</lpage><pub-id pub-id-type="pmid">15191940</pub-id></citation></ref><ref id="pone.0004061-Grisar1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grisar</surname><given-names>J</given-names></name><name><surname>Aletaha</surname><given-names>D</given-names></name><name><surname>Steiner</surname><given-names>CW</given-names></name><name><surname>Kapral</surname><given-names>T</given-names></name><name><surname>Steiner</surname><given-names>S</given-names></name><etal/></person-group><year>2005</year><article-title>Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis.</article-title><source>Circulation</source><volume>111</volume><fpage>204</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">15642766</pub-id></citation></ref><ref id="pone.0004061-Choi1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>KL</given-names></name><name><surname>Huh</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Byun</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>24</volume><fpage>1246</fpage><lpage>1252</lpage><pub-id pub-id-type="pmid">15155385</pub-id></citation></ref><ref id="pone.0004061-Ghani1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghani</surname><given-names>U</given-names></name><name><surname>Shuaib</surname><given-names>A</given-names></name><name><surname>Salam</surname><given-names>A</given-names></name><name><surname>Nasir</surname><given-names>A</given-names></name><name><surname>Shuaib</surname><given-names>U</given-names></name><etal/></person-group><year>2005</year><article-title>Endothelial progenitor cells during cerebrovascular disease.</article-title><source>Stroke</source><volume>36</volume><fpage>151</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">15576657</pub-id></citation></ref><ref id="pone.0004061-Foresta1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foresta</surname><given-names>C</given-names></name><name><surname>Caretta</surname><given-names>N</given-names></name><name><surname>Lana</surname><given-names>A</given-names></name><name><surname>Cabrelle</surname><given-names>A</given-names></name><name><surname>Palu</surname><given-names>G</given-names></name><etal/></person-group><year>2005</year><article-title>Circulating endothelial progenitor cells in subjects with erectile dysfunction.</article-title><source>Int J Impot Res</source><volume>17</volume><fpage>288</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">15729373</pub-id></citation></ref><ref id="pone.0004061-Xiao1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Kiechl</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Oberhollenzer</surname><given-names>F</given-names></name><name><surname>Weger</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis&#x02013;results from a large population-based study.</article-title><source>PLoS ONE</source><volume>2</volume><fpage>e975</fpage><pub-id pub-id-type="pmid">17925881</pub-id></citation></ref><ref id="pone.0004061-Nagasawa1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>T</given-names></name><name><surname>Hirota</surname><given-names>S</given-names></name><name><surname>Tachibana</surname><given-names>K</given-names></name><name><surname>Takakura</surname><given-names>N</given-names></name><name><surname>Nishikawa</surname><given-names>S</given-names></name><etal/></person-group><year>1996</year><article-title>Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.</article-title><source>Nature</source><volume>382</volume><fpage>635</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">8757135</pub-id></citation></ref><ref id="pone.0004061-Tachibana1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tachibana</surname><given-names>K</given-names></name><name><surname>Hirota</surname><given-names>S</given-names></name><name><surname>Iizasa</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Kawabata</surname><given-names>K</given-names></name><etal/></person-group><year>1998</year><article-title>The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract.</article-title><source>Nature</source><volume>393</volume><fpage>591</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">9634237</pub-id></citation></ref><ref id="pone.0004061-Zou1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>YR</given-names></name><name><surname>Kottmann</surname><given-names>AH</given-names></name><name><surname>Kuroda</surname><given-names>M</given-names></name><name><surname>Taniuchi</surname><given-names>I</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group><year>1998</year><article-title>Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.</article-title><source>Nature</source><volume>393</volume><fpage>595</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">9634238</pub-id></citation></ref><ref id="pone.0004061-Heissig1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Dias</surname><given-names>S</given-names></name><name><surname>Friedrich</surname><given-names>M</given-names></name><name><surname>Ferris</surname><given-names>B</given-names></name><etal/></person-group><year>2002</year><article-title>Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.</article-title><source>Cell</source><volume>109</volume><fpage>625</fpage><lpage>637</lpage><pub-id pub-id-type="pmid">12062105</pub-id></citation></ref><ref id="pone.0004061-Rafii1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rafii</surname><given-names>S</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name></person-group><year>2002</year><article-title>Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors.</article-title><source>Gene Ther</source><volume>9</volume><fpage>631</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">12032709</pub-id></citation></ref><ref id="pone.0004061-Moore1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>MA</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Shieh</surname><given-names>JH</given-names></name><name><surname>Dias</surname><given-names>S</given-names></name><etal/></person-group><year>2001</year><article-title>Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.</article-title><source>Ann N Y Acad Sci</source><volume>938</volume><fpage>36</fpage><lpage>45</lpage><comment>discussion 45&#x02013;37</comment><pub-id pub-id-type="pmid">11458524</pub-id></citation></ref><ref id="pone.0004061-Yamaguchi1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname><given-names>J</given-names></name><name><surname>Kusano</surname><given-names>KF</given-names></name><name><surname>Masuo</surname><given-names>O</given-names></name><name><surname>Kawamoto</surname><given-names>A</given-names></name><name><surname>Silver</surname><given-names>M</given-names></name><etal/></person-group><year>2003</year><article-title>Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization.</article-title><source>Circulation</source><volume>107</volume><fpage>1322</fpage><lpage>1328</lpage><pub-id pub-id-type="pmid">12628955</pub-id></citation></ref><ref id="pone.0004061-Hiasa1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiasa</surname><given-names>K</given-names></name><name><surname>Ishibashi</surname><given-names>M</given-names></name><name><surname>Ohtani</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><etal/></person-group><year>2004</year><article-title>Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.</article-title><source>Circulation</source><volume>109</volume><fpage>2454</fpage><lpage>2461</lpage><pub-id pub-id-type="pmid">15148275</pub-id></citation></ref><ref id="pone.0004061-DeFalco1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Falco</surname><given-names>E</given-names></name><name><surname>Porcelli</surname><given-names>D</given-names></name><name><surname>Torella</surname><given-names>AR</given-names></name><name><surname>Straino</surname><given-names>S</given-names></name><name><surname>Iachininoto</surname><given-names>MG</given-names></name><etal/></person-group><year>2004</year><article-title>SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells.</article-title><source>Blood</source><volume>104</volume><fpage>3472</fpage><lpage>3482</lpage><pub-id pub-id-type="pmid">15284120</pub-id></citation></ref><ref id="pone.0004061-Kimura1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>R</given-names></name><name><surname>Nishioka</surname><given-names>T</given-names></name><name><surname>Soemantri</surname><given-names>A</given-names></name><name><surname>Ishida</surname><given-names>T</given-names></name></person-group><year>2005</year><article-title>Allele-specific transcript quantification detects haplotypic variation in the levels of the SDF-1 transcripts.</article-title><source>Hum Mol Genet</source><volume>14</volume><fpage>1579</fpage><lpage>1585</lpage><pub-id pub-id-type="pmid">15843397</pub-id></citation></ref><ref id="pone.0004061-Soriano1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soriano</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>C</given-names></name><name><surname>Garcia</surname><given-names>F</given-names></name><name><surname>Plana</surname><given-names>M</given-names></name><name><surname>Palou</surname><given-names>E</given-names></name><etal/></person-group><year>2002</year><article-title>Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3&#x02032;A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.</article-title><source>J Infect Dis</source><volume>186</volume><fpage>922</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">12232832</pub-id></citation></ref><ref id="pone.0004061-Whittaker1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whittaker</surname><given-names>A</given-names></name><name><surname>Moore</surname><given-names>JS</given-names></name><name><surname>Vasa-Nicotera</surname><given-names>M</given-names></name><name><surname>Stevens</surname><given-names>S</given-names></name><name><surname>Samani</surname><given-names>NJ</given-names></name></person-group><year>2008</year><article-title>Evidence for genetic regulation of endothelial progenitor cells and their role as biological markers of atherosclerotic susceptibility.</article-title><source>Eur Heart J</source><volume>29</volume><fpage>332</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">18192701</pub-id></citation></ref><ref id="pone.0004061-Benboubker1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benboubker</surname><given-names>L</given-names></name><name><surname>Watier</surname><given-names>H</given-names></name><name><surname>Carion</surname><given-names>A</given-names></name><name><surname>Georget</surname><given-names>MT</given-names></name><name><surname>Desbois</surname><given-names>I</given-names></name><etal/></person-group><year>2001</year><article-title>Association between the SDF1-3&#x02032;A allele and high levels of CD34(&#x0002b;) progenitor cells mobilized into peripheral blood in humans.</article-title><source>Br J Haematol</source><volume>113</volume><fpage>247</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">11328308</pub-id></citation></ref><ref id="pone.0004061-Xu1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Willeit</surname><given-names>J</given-names></name><name><surname>Marosi</surname><given-names>M</given-names></name><name><surname>Kleindienst</surname><given-names>R</given-names></name><name><surname>Oberhollenzer</surname><given-names>F</given-names></name><etal/></person-group><year>1993</year><article-title>Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis.</article-title><source>Lancet</source><volume>341</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">8093914</pub-id></citation></ref><ref id="pone.0004061-Xu2"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Schett</surname><given-names>G</given-names></name><name><surname>Perschinka</surname><given-names>H</given-names></name><name><surname>Mayr</surname><given-names>M</given-names></name><name><surname>Egger</surname><given-names>G</given-names></name><etal/></person-group><year>2000</year><article-title>Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population.</article-title><source>Circulation</source><volume>102</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">10880409</pub-id></citation></ref><ref id="pone.0004061-Nagasawa2"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>T</given-names></name><name><surname>Tachibana</surname><given-names>K</given-names></name><name><surname>Iizasa</surname><given-names>H</given-names></name><name><surname>Bleul</surname><given-names>CC</given-names></name><etal/></person-group><year>1996</year><article-title>Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>14726</fpage><lpage>14729</lpage><pub-id pub-id-type="pmid">8962122</pub-id></citation></ref><ref id="pone.0004061-Aiuti1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aiuti</surname><given-names>A</given-names></name><name><surname>Webb</surname><given-names>IJ</given-names></name><name><surname>Bleul</surname><given-names>C</given-names></name><name><surname>Springer</surname><given-names>T</given-names></name><name><surname>Gutierrez-Ramos</surname><given-names>JC</given-names></name></person-group><year>1997</year><article-title>The chemokine SDF-1 is a chemoattractant for human CD34&#x0002b; hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34&#x0002b; progenitors to peripheral blood.</article-title><source>J Exp Med</source><volume>185</volume><fpage>111</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">8996247</pub-id></citation></ref><ref id="pone.0004061-Peled1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peled</surname><given-names>A</given-names></name><name><surname>Petit</surname><given-names>I</given-names></name><name><surname>Kollet</surname><given-names>O</given-names></name><name><surname>Magid</surname><given-names>M</given-names></name><name><surname>Ponomaryov</surname><given-names>T</given-names></name><etal/></person-group><year>1999</year><article-title>Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.</article-title><source>Science</source><volume>283</volume><fpage>845</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">9933168</pub-id></citation></ref><ref id="pone.0004061-Hattori1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name><name><surname>Honjo</surname><given-names>T</given-names></name><name><surname>Tateno</surname><given-names>M</given-names></name><etal/></person-group><year>2001</year><article-title>Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells.</article-title><source>Blood</source><volume>97</volume><fpage>3354</fpage><lpage>3360</lpage><pub-id pub-id-type="pmid">11369624</pub-id></citation></ref><ref id="pone.0004061-Petit1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname><given-names>I</given-names></name><name><surname>Szyper-Kravitz</surname><given-names>M</given-names></name><name><surname>Nagler</surname><given-names>A</given-names></name><name><surname>Lahav</surname><given-names>M</given-names></name><name><surname>Peled</surname><given-names>A</given-names></name><etal/></person-group><year>2002</year><article-title>G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.</article-title><source>Nat Immunol</source><volume>3</volume><fpage>687</fpage><lpage>694</lpage><pub-id pub-id-type="pmid">12068293</pub-id></citation></ref><ref id="pone.0004061-Winkler1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname><given-names>C</given-names></name><name><surname>Modi</surname><given-names>W</given-names></name><name><surname>Smith</surname><given-names>MW</given-names></name><name><surname>Nelson</surname><given-names>GW</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><etal/></person-group><year>1998</year><article-title>Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC).</article-title><source>Science</source><volume>279</volume><fpage>389</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">9430590</pub-id></citation></ref><ref id="pone.0004061-Mummidi1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mummidi</surname><given-names>S</given-names></name><name><surname>Ahuja</surname><given-names>SS</given-names></name><name><surname>Gonzalez</surname><given-names>E</given-names></name><name><surname>Anderson</surname><given-names>SA</given-names></name><name><surname>Santiago</surname><given-names>EN</given-names></name><etal/></person-group><year>1998</year><article-title>Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression.</article-title><source>Nat Med</source><volume>4</volume><fpage>786</fpage><lpage>793</lpage><pub-id pub-id-type="pmid">9662369</pub-id></citation></ref><ref id="pone.0004061-Brambilla1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brambilla</surname><given-names>A</given-names></name><name><surname>Villa</surname><given-names>C</given-names></name><name><surname>Rizzardi</surname><given-names>G</given-names></name><name><surname>Veglia</surname><given-names>F</given-names></name><name><surname>Ghezzi</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Shorter survival of SDF1-3&#x02032;A/3&#x02032;A homozygotes linked to CD4&#x0002b; T cell decrease in advanced human immunodeficiency virus type 1 infection.</article-title><source>J Infect Dis</source><volume>182</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">10882614</pub-id></citation></ref><ref id="pone.0004061-Dommange1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dommange</surname><given-names>F</given-names></name><name><surname>Cartron</surname><given-names>G</given-names></name><name><surname>Espanel</surname><given-names>C</given-names></name><name><surname>Gallay</surname><given-names>N</given-names></name><name><surname>Domenech</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia.</article-title><source>Faseb J</source><volume>20</volume><fpage>1913</fpage><lpage>1915</lpage><pub-id pub-id-type="pmid">16818471</pub-id></citation></ref><ref id="pone.0004061-deOliveira1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Oliveira</surname><given-names>CE</given-names></name><name><surname>Cavassin</surname><given-names>GG</given-names></name><name><surname>Perim Ade</surname><given-names>L</given-names></name><name><surname>Nasser</surname><given-names>TF</given-names></name><name><surname>de Oliveira</surname><given-names>KB</given-names></name><etal/></person-group><year>2007</year><article-title>Stromal cell-derived factor-1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients.</article-title><source>J Clin Lab Anal</source><volume>21</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17245764</pub-id></citation></ref><ref id="pone.0004061-Dimberg1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dimberg</surname><given-names>J</given-names></name><name><surname>Hugander</surname><given-names>A</given-names></name><name><surname>Lofgren</surname><given-names>S</given-names></name><name><surname>Wagsater</surname><given-names>D</given-names></name></person-group><year>2007</year><article-title>Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.</article-title><source>Int J Mol Med</source><volume>19</volume><fpage>11</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">17143542</pub-id></citation></ref><ref id="pone.0004061-Zafiropoulos1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zafiropoulos</surname><given-names>A</given-names></name><name><surname>Crikas</surname><given-names>N</given-names></name><name><surname>Passam</surname><given-names>AM</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name></person-group><year>2004</year><article-title>Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer.</article-title><source>J Med Genet</source><volume>41</volume><fpage>e59</fpage><pub-id pub-id-type="pmid">15121787</pub-id></citation></ref><ref id="pone.0004061-Ghilardi1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghilardi</surname><given-names>G</given-names></name><name><surname>Biondi</surname><given-names>ML</given-names></name><name><surname>Turri</surname><given-names>O</given-names></name><name><surname>Pateri</surname><given-names>F</given-names></name><name><surname>d'Eril</surname><given-names>GM</given-names></name><etal/></person-group><year>2008</year><article-title>Genetic control of chemokines in severe human internal carotid artery stenosis.</article-title><source>Cytokine</source><volume>41</volume><fpage>24</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">18060801</pub-id></citation></ref><ref id="pone.0004061-Ide1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ide</surname><given-names>A</given-names></name><name><surname>Kawasaki</surname><given-names>E</given-names></name><name><surname>Abiru</surname><given-names>N</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Fukushima</surname><given-names>T</given-names></name><etal/></person-group><year>2003</year><article-title>Stromal-cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population.</article-title><source>Hum Immunol</source><volume>64</volume><fpage>973</fpage><lpage>978</lpage><pub-id pub-id-type="pmid">14522095</pub-id></citation></ref><ref id="pone.0004061-Lima1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>G</given-names></name><name><surname>Soto-Vega</surname><given-names>E</given-names></name><name><surname>Atisha-Fregoso</surname><given-names>Y</given-names></name><name><surname>Sanchez-Guerrero</surname><given-names>J</given-names></name><name><surname>Vallejo</surname><given-names>M</given-names></name><etal/></person-group><year>2007</year><article-title>MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus.</article-title><source>Hum Immunol</source><volume>68</volume><fpage>980</fpage><lpage>985</lpage><pub-id pub-id-type="pmid">18191726</pub-id></citation></ref><ref id="pone.0004061-Arya1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arya</surname><given-names>SK</given-names></name><name><surname>Ginsberg</surname><given-names>CC</given-names></name><name><surname>Davis-Warren</surname><given-names>A</given-names></name><name><surname>D'Costa</surname><given-names>J</given-names></name></person-group><year>1999</year><article-title>In vitro phenotype of SDF1 gene mutant that delays the onset of human immunodeficiency virus disease in vivo.</article-title><source>J Hum Virol</source><volume>2</volume><fpage>133</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">10413364</pub-id></citation></ref><ref id="pone.0004061-Nagasawa3"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>T</given-names></name><name><surname>Kikutani</surname><given-names>H</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name></person-group><year>1994</year><article-title>Molecular cloning and structure of a pre-B-cell growth-stimulating factor.</article-title><source>Proc Natl Acad Sci U S A</source><volume>91</volume><fpage>2305</fpage><lpage>2309</lpage><pub-id pub-id-type="pmid">8134392</pub-id></citation></ref><ref id="pone.0004061-Shirozu1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shirozu</surname><given-names>M</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Inazawa</surname><given-names>J</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name><name><surname>Tada</surname><given-names>H</given-names></name><etal/></person-group><year>1995</year><article-title>Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene.</article-title><source>Genomics</source><volume>28</volume><fpage>495</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">7490086</pub-id></citation></ref><ref id="pone.0004061-Prater1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prater</surname><given-names>DN</given-names></name><name><surname>Case</surname><given-names>J</given-names></name><name><surname>Ingram</surname><given-names>DA</given-names></name><name><surname>Yoder</surname><given-names>MC</given-names></name></person-group><year>2007</year><article-title>Working hypothesis to redefine endothelial progenitor cells.</article-title><source>Leukemia</source><volume>21</volume><fpage>1141</fpage><lpage>1149</lpage><pub-id pub-id-type="pmid">17392816</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>QX thanks support from the British Heart Foundation and Oak Foundation, and SY thanks support from the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 